A limited report applies where the plan sponsor is in the drug supply chain
What the document says“The Secretary shall define through rulemaking a limited form of the report under paragraph (1) required with respect to any group health plan established by a plan sponsor that is, or is affiliated with, a drug manufacturer, drug wholesaler, or other direct participant in the drug supply chain, in order to prevent anti-competitive behavior.”
The Secretary must define by rulemaking a limited form of the report for a group health plan set up by a sponsor that is, or is affiliated with, a drug manufacturer, wholesaler or other direct participant in the drug supply chain, in order to prevent anti-competitive behavior.
What the document actually says“The Secretary shall define through rulemaking a limited form of the report under paragraph (1) required with respect to any group health plan established by a plan sponsor that is, or is affiliated with, a drug manufacturer, drug wholesaler, or other direct participant in the drug supply chain, in order to prevent anti-competitive behavior.”
The health chief must write a rule making a shorter report. It applies where the plan's sponsor is part of the drug trade.
The full report holds rival firms' prices. In the hands of a drug maker that could distort the market. So that sponsor sees less.
No action is recorded against this proposal. That is not evidence that none has been taken, and nobody has yet read it against the record. See what the tracker does not yet cover.